Triumvira Immunologics Inc.
$74,900.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- November 5, 2018 – November 1, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q4-914154
Published purpose
Triumvira Immunologics has developed a potent new personalized cell therapy for cancer. The personalized nature of the product is a major driver of cost and can delay patient access. In this project, Triumvira will work to develop an off-the-shelf solution, which should lower cost and improve patient access.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions